Advanced Search
Contact | Corporate | Help

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

Sponsors:
  • Retina Vitreous Associates of Florida
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Diabetic Retinopathy
  • Macular Edema
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Ranibizumab
  • Drug: Ranibizumab
Enrollment:
20

Additional information about NCT01476449.


SourceSolution © 2008-2012